Hybrid immunity and vaccine Imprinting: Powerful defenses against Omicron reinfection

FHS
June 26, 2023
3:16 am

Recent research explores the impact of hybrid immunity and vaccine-only imprinting on omicron reinfection. Findings suggest effective protection and immune response in a long-term imprinted population.

Born out of Omega push for pandemic treatments, Aerium Therapeutics enters long Covid R&D

Aerium Therapeutics, which Omega Funds seeded in 2021 and unveiled in spring 2022 to take on Covid-19 with new monoclonal antibodies, will attempt to treat

August 5, 2023

Purdue receives clearance for opioid overdose injector for younger individuals – Pharmaceutical Technology

Purdue Pharma has drawn heavy criticism in the past and has been the subject of numerous lawsuits as many accuse the company of being responsible

August 8, 2024

Diverting Acute HF Patients From Hospitalization: Case Builds for Short Stay Units

For patients presenting to the emergency department (ED) with acute heart failure (AHF), sending select low-risk individuals to the short stay unit (SSU) did not

January 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.